peptide,Qualitative Measure,Measurement Inequality,Quantitative measurement,Units,Allele Name,MHC allele class,Ref Type,Ref Date,Ref Title,Assay Method,Assay Group,Host Name,Description_Length,Normalized_QM,netmhcpan_ba_BAV,ann_BAV,smmpmbec_BAV,smm_BAV,mhcflurry_BAV,netmhcpan_ba_BAV_Normalized,ann_BAV_Normalized,smmpmbec_BAV_Normalized,smm_BAV_Normalized,mhcflurry_BAV_Normalized,VTAPERNet_BAV_Normalized,VTAPERNet_BAV
EPRSPSHSM,Positive,=,27.0,nM,HLA-B*07:02,I,Literature,2023,Molecular mechanism of phosphopeptide neoantigen immunogenicity.,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),Homo sapiens (human),9,0.6953877630974059,19.57,9.73,17.91265659143932,18.53062212293167,42.42,0.7251332048371933,0.7897171424042798,0.7333117685697856,0.7301770390468458,0.6536324635656992,0.5861228108406067,88.06361259047364
LPASPAHQL,Positive,=,54.3,nM,HLA-B*07:02,I,Literature,2023,Molecular mechanism of phosphopeptide neoantigen immunogenicity.,purified MHC/direct/fluorescence,dissociation constant KD (~EC50),Homo sapiens (human),9,0.6308127466257405,27.3,22.85,33.27821321810366,36.46615721545553,31.74,0.694366500378695,0.710811900660795,0.6760651805405413,0.6676101361449955,0.6804391343138587,0.44379982352256775,410.7408955471499
APFARVLNL,Positive,,0.21,nM,HLA-B*07:02,I,Literature,2024,"Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.",purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),Homo sapiens (human),9,1.1442402706637098,33.14,73.34,105.96440405655926,99.058101443723,35.44,0.6764498384368492,0.6030319614929818,0.5690204453037018,0.5752494699565496,0.6702482221028857,0.6322311758995056,53.47301513666299
YPQLSAIAL,Positive,,44.0,nM,HLA-B*07:02,I,Literature,2024,"Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.",purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),Homo sapiens (human),9,0.6502525713146337,15.19,10.54,13.248295305335242,13.928039827995688,32.42,0.7485496241149672,0.7823266354259142,0.7611902185022428,0.7565658008149734,0.6784799628177283,0.498809814453125,226.50492439377902
EVASFKQAL,Positive,,250.0,nM,HLA-B*07:02,I,Literature,2024,"Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.",purified MHC/competitive/radioactivity,dissociation constant KD (~IC50),Homo sapiens (human),9,0.4896881643297754,3903.81,5030.47,1746.465456064331,1949.350797154922,1108.86,0.2356859760951563,0.2122510763114991,0.3100275173052256,0.2998699721504453,0.3520118846032481,0.0918806716799736,18502.29001888444
